SAUDI-MINISTRY-ECONOMY
20.1.2023 18:38:34 CET | Business Wire | Press release
Saudi Arabia’s smart city NEOM offers a new model for environmentally-friendly and sustainable urban design, both for the Kingdom and the world, Saudi’s Climate Envoy told the World Economic Forum (WEF) today.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230120005356/en/
Saudi’s Climate Envoy speaks at the World Economic Forum about creating sustainable future cities (Photo: AETOSWire)
During a panel session titled ‘The Evolution of Urban Life’, His Excellency Adel bin Ahmed Al-Jubeir, Minister of State for Foreign Affairs and Climate Envoy for Saudi Arabia, said: “[The Line] will revolutionize the way people look at cities and urban planning. NEOM is an attempt to create a city that is environmentally friendly, sustainable, that has a very high quality of life, that has virtually no traffic.”
His Excellency Khalid bin Abdulaziz Al-Falih, Minister of Investment, participated in a session called ‘Reshuffling Value Chains’. He described how Saudi Arabia’s supply chain initiatives will leverage the Kingdom’s resources, infrastructure, and location to enhance local and global supply chain resilience.
“In Saudi Arabia, we launched the Global Supply Chain Resilience Initiative (GCSRI), to not only strengthen our resilience but also enable the Kingdom to become part of the global multi-hub system, while playing to our strengths.”
During a session titled Deployment in the Industrial Metaverse, His Excellency Abdullah bin Amer Alswaha, Minister of Communications & Information Technology, said: “The current 2D world that we live in today is not fit for purpose in the 21st century.
“I'm a big advocate of the metaverse, which is going to be the next wave of how immersive experiences work for consumers, enterprises, and industry. We are bringing together academics, innovators, policymakers and regulators into a sandbox to make sure that they have a safe environment to innovate.”
His Excellency Faisal F. Alibrahim, Saudi Arabia’s Minister of Economy and Planning told the WEF audience the Kingdom is set to surpass projected growth rates for 2023.
“Saudi is becoming the global growth story. We had the strongest growth in the G20 last year and if you look more closely at the 8.5 percent GDP growth figure, you will see that our non-oil activities and our private sector grew at a very high rate,” he said.
Earlier, Alibrahim addressed a panel on global tax reform, where he said: “Under Saudi Vision 2030, we have been focusing on detaching ourselves from traditional sources of revenue, with our economic diversification, to think about more long-term sustainable revenue generation, but also diversifying our sources of growth.”
In addition to the panel sessions, the Ministry of Economy and Planning for Saudi Arabia joined forces with WEF’s open innovation platform UpLink to launch a challenge designed to enhance food security in countries with arid climates. The Food Ecosystems and Arid Climates Challenge is a global call for technology solutions to food insecurity.
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230120005356/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release
The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom